| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.15 | 0.02 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |